Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Kromek awarded huge osteoporosis scanner contract

The contract is worth US$12.6mln (£8.7mln), or more than last year’s total sales, spread over five years.
Kromek awarded huge osteoporosis scanner contract
Scanners will allow clinicians to accurately detect and monitor progression of osteoporosis.

Image technology group Kromek (LON:KMK) has been awarded a huge contract from an existing customer to provide bone density scanning detectors to detect osteoporosis.

The contract is worth US$12.6mln (£8.7mln), or more than last year’s total sales, spread over five years.

The detectors, part of a new generation of bone density scanners, will start to be delivered in first half of the financial year to April 2017.

Kromek said the detector modules will produce some of the most accurate imaging to diagnose the strength and health of bones and allow clinicians to accurately detect and monitor progression of osteoporosis. 

Arnab Basu, Kromek’s chief executive, added it was a significant contract that further validated its BMD [bone] diagnostic systems and continued the trend for conversion of pipeline into orders in the medical scanning market. 

Speaking to Proactive, Basu confirmed the contract was an expansion of a relationship with a large exisiting client and was only a taste of things to come.

Shares were up 4.8% to 33p.

--UPDATE SHARE PRICE, CEO COMMENT--

View full KMK profile View Profile

Kromek Group PLC Timeline

Related Articles

Male model
July 09 2018
Clothes maketh the man ... and the chances are, those clothes were bought from a website that uses ATTRQT's technology
The D3S detector kit
April 20 2018
Kromek, formerly Durham Scientific Crystals, was incorporated in April 2003 to commercialise technology that had been developed in the Physics Department of Durham University over a period of some 20 years.
The Internet of Things
April 30 2018
Richard Kilsby, the non-executive chairman of Telit, said that the early signs of changes made, especially to the group's activities and cost base, have led to positive operational progress since the beginning of 2018

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use